Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B

BACKGROUND: Liver biopsy for evaluation of liver fibrosis has several adverse effects, for which reason noninvasive tests have been developed. AIM: To evaluate the usefulness of noninvasive biomarkers, qHBsAg and HBV DNA levels in predicting liver fibrosis in patients with hepatitis Be antigen (HBeA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimzova, Marija, Kondova-Topuzovska, Irena, Bosilkovski, Mile, Ivanovski, Ljubomir, Milenkovic, Zvonko, Semenakova-Cvetkovska, Vesna, Orovcanec, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026435/
https://www.ncbi.nlm.nih.gov/pubmed/29983800
http://dx.doi.org/10.3889/oamjms.2018.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026435/
https://www.ncbi.nlm.nih.gov/pubmed/29983800
http://dx.doi.org/10.3889/oamjms.2018.122

Ejemplares similares